[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352252-105":59,"doc-detail-352252-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cell-type-specific-activation-of-the-cgas-sting-pathway-in-tumor-immunotherapy-mechanisms-and-therapeutic-implications","Cell-type specific activation of the cGAS-STING pathway in tumor immunotherapy - mechanisms and therapeutic implications","","cGAS–STING is a pivotal innate immune sensor that detects cytosolic DNA and links genomic instability to antitumor immune activation. Therapeutic pathway activation is pursued to enhance cancer immunotherapy by supporting dendritic cell maturation, antigen presentation, and cytotoxic lymphocyte infiltration, yet outcomes depend strongly on cell type and the tumor microenvironment. Recent single-cell and spatial profiling shows marked heterogeneity: acute, localized activation can drive strong antitumor responses, whereas chronic or dysregulated signaling may induce tolerance and progression. Metabolic stress, epigenetic silencing, and immunosuppressive factors can further modulate STING activity, contributing to resistance. Translational approaches target next-generation STING agonists, delivery platforms, and rational combinations with checkpoint blockade and metabolic modulators.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cell-type-specific-activation-of-the-cgas-sting-pathway-in-tumor-immunotherapy-mechanisms-and-therapeutic-implications/352252/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cell-type-specific-activation-of-the-cgas-sting-pathway-in-tumor-immunotherapy-mechanisms-and-therapeutic-implications/352252.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the cGAS–STING pathway’s role in tumor immunotherapy?","Question",{"text":113,"@type":114},"cGAS–STING detects cytosolic DNA and connects genomic instability to antitumor immune activation, supporting dendritic cell maturation, antigen presentation, and cytotoxic lymphocyte infiltration when appropriately stimulated.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why do cGAS–STING therapeutic outcomes vary across tumors?",{"text":118,"@type":114},"Outcomes are highly context dependent and influenced by both cell type and tumor microenvironment conditions, which shape whether signaling leads to effective immunity or immunosuppressive/tumor-promoting effects.",{"name":120,"@type":111,"acceptedAnswer":121},"Which factors can modulate STING activity and contribute to immunotherapy resistance?",{"text":122,"@type":114},"Metabolic stress, epigenetic silencing, and immunosuppressive microenvironmental factors such as TGF-β and IL-10 can modulate STING activity and promote resistance to immunotherapy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352252,1790127415,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":14,"preview_urls":147},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Wang et al. Journal of Translational Medicine (2026) 24:43  \n[https://doi.org/10.1186/s12967-025-07645-2](https://doi.org/10.1186/s12967-025-07645-2)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nCell-type specific activation of the cGASSTING pathway in tumor immunotherapy: mechanisms and therapeutic implications  \nLusheng Wang1,3†, Sudi Zhu1†, Zhixian Ding1,3, Jie Hong1, Lijie Zheng1,3, Jiting Sun1,3, Yu Tang1,3, Xiaohui Chen1,3, Xiang Yong3, Mengxue Hu1,3, Zhimin Jiang4, Yan Liu5, Dan Wang2 and Heng Tang1,3*  \nAbstract  \nBackground The cyclic GMP–AMP synthase–stimulator of interferon genes (cGAS–STING) pathway acts as a pivotal innate immune sensor that detects cytosolic DNA and links genomic instability to antitumor immune activation. Therapeutic activation of this pathway has garnered substantial interest as a strategy to enhance cancer immunotherapy by promoting dendritic cell maturation, augmenting antigen presentation, and facilitating cytotoxic lymphocyte infiltration. However, the functional outcomes of cGAS–STING signaling are highly context dependent and influenced by both cell type and tumor microenvironmental (TME) conditions.  \nMain body Recent advances in single-cell and spatial transcriptomic profiling have revealed profound heterogeneity in cGAS–STING activation across distinct cellular and regional compartments within tumors. Acute and spatially restricted activation of the pathway can elicit potent antitumor immune responses, whereas chronic or dysregulated signaling may promote immune tolerance and tumor progression. Moreover, metabolic stress, epigenetic silencing, and microenvironmental immunosuppressive factors such asTGF-β and IL-10 can further modulate STING activity, leading to resistance to immunotherapy. Current translational efforts focus on next-generation STING agonists, nanoparticle-based delivery systems, and rational combination strategies with immune checkpoint blockade and metabolic modulators to overcome tumor-intrinsic resistance and minimize systemic toxicity.  \nConclusions Understanding the cell-type-specific and spatial dynamics of cGAS–STING signaling is crucial for the rational design of precision immunotherapies. Future research should emphasize context-dependent modulation of STING activity to maximize therapeutic benefit while limiting adverse effects. Integrating multi-omics technologies and spatially guided drug delivery may ultimately enable personalized modulation of the cGAS–STING axis, transforming it into a clinically effective and safe strategy for cancer immunotherapy.  \nKeywords cGAS-STING pathway, Cell-type specific activation, Tumor microenvironment, Innate immune sensing, Spatial and temporal regulation  \n†Lusheng Wang and Sudi Zhu contributed equally to this work.  \n*Correspondence:  \nHeng Tang [tangheng@mail.ustc.edu.cn](tangheng@mail.ustc.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc","cbCainUon53VUmVe","https://ap.wps.com/l/cbCainUon53VUmVe","pdf",1902743,18,"English","# Abstract\n# Introduction\n## Innate immunity and cytosolic DNA sensing\n## cGAS–STING in the tumor microenvironment\n# Main body\n## Cellular and spatial heterogeneity of activation\n## Context-dependent effects: antitumor vs tolerance\n## Modulation by metabolism, epigenetics, and immunosuppression\n## Translational strategies and combination approaches\n# Conclusions\n## Precision immunotherapy via context-dependent STING control","[{\"question\":\"What is the cGAS–STING pathway’s role in tumor immunotherapy?\",\"answer\":\"cGAS–STING detects cytosolic DNA and connects genomic instability to antitumor immune activation, supporting dendritic cell maturation, antigen presentation, and cytotoxic lymphocyte infiltration when appropriately stimulated.\"},{\"question\":\"Why do cGAS–STING therapeutic outcomes vary across tumors?\",\"answer\":\"Outcomes are highly context dependent and influenced by both cell type and tumor microenvironment conditions, which shape whether signaling leads to effective immunity or immunosuppressive/tumor-promoting effects.\"},{\"question\":\"Which factors can modulate STING activity and contribute to immunotherapy resistance?\",\"answer\":\"Metabolic stress, epigenetic silencing, and immunosuppressive microenvironmental factors such as TGF-β and IL-10 can modulate STING activity and promote resistance to immunotherapy.\"}]","Cell-type specific activation of the cGAS-STING pathway in tumor immunotherapy - mechanisms and therapeutic implications | PDF",1790098564,45,[148,152],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/9269334196187ca71e7162a22c0cb63c.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/339afa94902b77caa6bec4782ecd18b1.webp",982,1309]